UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 2, 2016
ROCKWELL MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Michigan |
| 000-23661 |
| 38-3317208 |
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
of incorporation) |
| File Number) |
| Identification No.) |
30142 Wixom Road, Wixom, Michigan |
| 48393 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code (248) 960-9009
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 2, 2016, Rockwell Medical, Inc. (the “Company”) held its Annual Meeting of Shareholders. At the Annual Meeting the shareholders (1) reelected one incumbent director for a term expiring in 2019, (2) did not approve the Company’s 2016 Long Term Incentive Plan, and (3) ratified the selection of Plante & Moran, PLLC as the Company’s independent registered public accounting firm for 2016. The following tables set forth the final voting results on each matter.
Director Nominee |
| For |
| Withheld |
| Broker Non-Votes |
|
Ronald D. Boyd |
| 14,011,364 |
| 10,981,850 |
| 22,314,175 |
|
Proposal |
| For |
| Against |
| Abstain |
| Broker Non- |
|
Approve the 2016 LTIP |
| 11,977,282 |
| 12,806,542 |
| 209,390 |
| 22,314,175 |
|
Ratify the selection of Plante & Moran, PLLC |
| 43,453,090 |
| 3,746,013 |
| 108,286 |
| — |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ROCKWELL MEDICAL, INC. | |
|
| |
|
|
|
Date: June 6, 2016 | By: | /s/ Thomas E. Klema |
|
| Thomas E. Klema |
|
| Its: Chief Financial Officer |